CN1323711C - Chinese medicine for treating liver cancer and carcinoma of pancreas - Google Patents
Chinese medicine for treating liver cancer and carcinoma of pancreas Download PDFInfo
- Publication number
- CN1323711C CN1323711C CNB2005100103973A CN200510010397A CN1323711C CN 1323711 C CN1323711 C CN 1323711C CN B2005100103973 A CNB2005100103973 A CN B2005100103973A CN 200510010397 A CN200510010397 A CN 200510010397A CN 1323711 C CN1323711 C CN 1323711C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- pancreas
- cancers
- radix
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 208000014018 liver neoplasm Diseases 0.000 title abstract 3
- 208000021045 exocrine pancreatic carcinoma Diseases 0.000 title 1
- 201000007270 liver cancer Diseases 0.000 title 1
- 208000008443 pancreatic carcinoma Diseases 0.000 title 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims abstract description 13
- 241000218176 Corydalis Species 0.000 claims abstract description 4
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 4
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims abstract description 3
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 11
- 241001489978 Eupolyphaga Species 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 3
- 241000237903 Hirudo Species 0.000 claims description 3
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 241000283956 Manis Species 0.000 claims description 3
- 241000131808 Scolopendra Species 0.000 claims description 3
- 241000522620 Scorpio Species 0.000 claims description 3
- 108010052008 colla corii asini Proteins 0.000 claims description 3
- 210000003038 endothelium Anatomy 0.000 claims description 3
- 239000009490 scorpio Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 8
- 208000024891 symptom Diseases 0.000 abstract description 4
- 230000004083 survival effect Effects 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract 3
- BWVZAZPLUTUBKD-HXLKAFCPSA-N 3-[(1r,4r)-2,2,3-trimethyl-5-bicyclo[2.2.1]heptanyl]cyclohexan-1-ol Chemical compound C([C@@]1(C[C@]2(C(C1(C)C)C)[H])[H])C2C1CCCC(O)C1 BWVZAZPLUTUBKD-HXLKAFCPSA-N 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 241000092665 Atractylodes macrocephala Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 240000000233 Melia azedarach Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 241000915604 Scutellaria barbata Species 0.000 abstract 1
- 241000195974 Selaginella Species 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000005272 common selfheal Nutrition 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 244000132619 red sage Species 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 6
- 208000037920 primary disease Diseases 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 4
- 230000002440 hepatic effect Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000007096 poisonous effect Effects 0.000 description 4
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 206010058019 Cancer Pain Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010058117 Ocular icterus Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a traditional Chinese medicine for treating liver cancers and pancreas cancers, which is prepared from 50g of milkvetch root, 40g of centipede, 15g of scorpion, 50g of doederlein's spikemoss herb, 40g of Chinese sage herb, 40g of barbed skullcap herb, 30g of common selfheal fruit-spike, 30g of Lufengfang, 200g of honeysuckle flower, 30g of turtle shell, 20g of pangolin scale, 30g of notoginseng, 30g of chicken's gizzard-membrane, 30g of amomun fruit, 30g of sandenol, 30g of corydalis tuber, 20g of szechwan chinaberry fruit, 20g of sauted atractylodes macrocephala, 20g of ecliptae herba, 20g of glossy privet fruit, 20g of leech, 20g of ground beeltle, 30g of donkey-hide gelatin, 15g of bupleurum root, 20g of curcuma root and 15g of liquorice in a powder mode. The traditional Chinese medicine can effectively control the development of diseases in a short term, lightens pain symptoms caused by cancers, prolongs the survival time of patients and enhances the life quality of the patients. The traditional Chinese medicine of the present invention has treatment effect on liver cancers or combination pancreas cancers, and the value of economic effect, practicality, high safety and reliability.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine for the treatment of hepatocarcinoma, cancer of pancreas.
Background technology
Chinese medicine thinks that hepatocarcinoma belongs to " lump in the abdomen " " jaundice " expansion category, ancient medicine is extremely complicated to the argumentation of carninomatosis, each carninomatosis all has several even more etiology and pathogenesis determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, also complicated thereupon in treatment, if go out tcm product, just can not go out a kind of medicine to each disease type, so, on medical market, be difficult to find the medicine of comprehensive therapy.Two kinds of medicines are so arranged on the market now, be not easy to detail here,,, can think and it that this is not popular medicine though curative effect is not fine can on price, but surpass gold.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine for the treatment of hepatocarcinoma, cancer of pancreas, effectively disease controlling development in a short time; Alleviate the pain that produces by carninomatosis; Prolong patient's life span.
Medicament selection Radix Astragali QI invigorating and body resistance strengthening of the present invention, other has stronger antitumor action, Scolopendra, and Scorpio, Herba Salviae Chinensis, Herba Scutellariae Barbatae, Spica Prunellae, Nidus Vespae all have the optimum efficiency of treatment malignant tumor, scrofula, and can hard masses softening and resolving, the method for the treating the poisonous disease with poisonous drugs that also to be the traditional Chinese medical science take primary disease.Flos Lonicerae can effectively be controlled the xerostomia of malignant tumor in radiotherapy or chemotherapeutic period generation, and the effect of antidotal therapy scrofula is arranged simultaneously.The Radix Curcumae promoting blood circulation and stopping pain, the promoting QI circulation for relieving depression jaundice eliminating; Carapax Trionycis, Squama Manis, Hirudo, Eupolyphaga Seu Steleophaga activating blood circulation to dissipate blood stasis and dredge the collateral, hard masses softening and resolving.The Radix Notoginseng reducing swelling and alleviating pain has work in ending, have in living and end, the hemorrhage effect of pathologic that wherein has the prevention primary disease to produce, more than all medicines the treatment primary disease is played an important role, be monarch drug.Endothelium Corneum Gigeriae Galli, Fructus Amomi, Lignum Santali Albi, Rhizoma Corydalis, Fructus Toosendan play depressed liver-energy dispersing and QI regulating to primary disease, help digestion to remove to expand analgesic effect.Colla Corii Asini nourishing blood, hemostasis.Rhizoma Atractylodis Macrocephalae (Rhizoma Atractylodis Macrocephalae stir-fry) the spleen strengthening and damp drying is promoted spleen and stomach function, Gu The spleen and stomach provide the material basis of the acquired, thereby with stimulating appetite enhancing body resistance against diseases, above medicine is a ministerial drug.According to traditional Chinese medical science hepatopathy with the passing of time involve kidney, The liver and the kidney have a common source says, utilize Herba Ecliptae, Fructus Ligustri Lucidi to mend its kidney and be adjuvant drug.The Radix Bupleuri priming is gone into liver, and the Radix Glycyrrhizae mediation property of medicine is messenger drug.
The present invention makes powder by the following raw materials in weight medicine: Radix Astragali 50g, Scolopendra 40g, Scorpio 15g, Herba Selaginellae Doederleinii 50g, Herba Salviae Chinensis 40g, Herba Scutellariae Barbatae 40g, Spica Prunellae 30g, Nidus Vespae 30g, Flos Lonicerae 200g, Carapax Trionycis 30g, Squama Manis 20g, Radix Notoginseng 30g, Endothelium Corneum Gigeriae Galli 30g, Fructus Amomi 30g, Lignum Santali Albi 30g, Rhizoma Corydalis 30g, Fructus Toosendan 20g, Rhizoma Atractylodis Macrocephalae 20g, Herba Ecliptae 20g, Fructus Ligustri Lucidi 20g, Hirudo 20g, Eupolyphaga Seu Steleophaga 20g, Colla Corii Asini 30g, Radix Bupleuri 15g, Radix Curcumae 20g and Radix Glycyrrhizae 15g.
The present invention is hepatocarcinoma: depression of liver-QI, qi depression to blood stasis, damp-heat accumulation, weakness of the spleen and stomach, the hepatic and renal YIN deficiency.Cancer of pancreas: damp and hot poison is contained, and turbid damp checks, these disease types of deficiency of both QI and blood.On method of treatment, reduce: hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, treating the poisonous disease with poisonous drugs, the tonify deficiency that nourishes blood, reinforcing kidney and strengthening resistance, heat-clearing and toxic substances removing, supplementing QI and nourishing YIN, depressed liver-energy dispersing and QI regulating, pain relieving, the spleen reinforcing dampness removing is enriched blood and is set upright, and primary disease is treated.Chinese medicine characteristics of the present invention: effectively disease controlling development in a short time; Can alleviate the pain symptom that produces by carninomatosis; Prolong patient's life span; Improve patient's life quality; No matter medicine of the present invention is hepatocarcinoma or merge cancer of pancreas, all effective in cure; Chinese traditional medicinal economy practicality of the present invention, safe and reliable.The characteristics of Chinese medicine maximum of the present invention, the effect that ends cancer pain is strong especially.
The specific embodiment
Below by clinical observation on the therapeutic effect test, further set forth the beneficial effect of Chinese medicine of the present invention
1, physical data
In the past few years treat hepatocarcinoma 35 examples, cancer of pancreas 39 examples.
2, diagnostic criteria
Hepatocarcinoma: there is lump the abdominal part hepatic region, or expand or pain or quality harder, migratory pain, or fixingly do not move, visible face is dim simultaneously becomes thin, right rib distension, temperament and interest depression, or jaundice is arranged, the poor appetite of feeling sick, tongue limit purple is secretly seen petechia, hesitant pulse or string etc.
Cancer of pancreas: the upper abdomen distension, twinge under the rib, dark pressure can be scratched and the Zhong piece jaundice color depth, or yellow skin and eye, skin pruritus, wrist stomachache is involved lower back, and pain can be persistence, or is paroxysmal, and night is more so, nausea and vomiting is indigestion and loss of appetite, and pale tongue has ecchymosis point, hesitant pulse or string.
3, Therapeutic Method
Chinese medicine of the present invention is taken 5 grams at every turn, and 3 times on the one, one after each meal, 60 days is a course of treatment.
4, efficacy assessment standard
Cure: take medicine by secular, all symptoms that caused by carninomatosis are by heavily to gently.Along with improvement progressively, reach the state that thoroughly refreshes at last, body weight, muscle power, quality of life, all reach normal person's health level.Produce effects: after taking medicine potion of the present invention, the degree of stomachache, abdominal distention, indigestion and loss of appetite, hepatic region or pancreatic gland pain all alleviates to some extent.The original lump in hepatic region or pancreas position has the trend of deliquescing.Take medicine along with secular, the yellowish body icteric sclera also alleviates simultaneously, and appetite sees and increase that the health of skeletonize also has alleviation slightly, and spirit is amelioration progressively, and quality of life increases.Invalid: as after the oral administration 1-2 agent of the present invention, all not have the improvement phenomenon by a series of symptoms that hepatocarcinoma and cancer of pancreas are showed.
5, result
Cure: hepatocarcinoma 3 examples, cancer of pancreas: 2 examples.Produce effects: the hepatocarcinoma survival rate is respectively: 2 years: 16 examples; 3 years: 9 examples; 4 years: 4 examples; 5 years: 3 examples.The cancer of pancreas survival rate is respectively: 2 years: 14 examples; 3 years: 14 examples; 4 years: 7 examples; 5 years: 2 examples.Invalid: 0 example.Cure rate: 5.4%, total effective rate: 100%.
Claims (1)
1, a kind of Chinese medicine for the treatment of hepatocarcinoma, cancer of pancreas, it is characterized in that, make powder: Radix Astragali 50g, Scolopendra 40g, Scorpio 15g, Herba Selaginellae Doederleinii 50g, Herba Salviae Chinensis 40g, Herba Scutellariae Barbatae 40g, Spica Prunellae 30g, Nidus Vespae 30g, Flos Lonicerae 200g, Carapax Trionycis 30g, Squama Manis 20g, Radix Notoginseng 30g, Endothelium Corneum Gigeriae Galli 30g, Fructus Amomi 30g, Lignum Santali Albi 30g, Rhizoma Corydalis 30g, Fructus Toosendan 20g, Rhizoma Atractylodis Macrocephalae 20g, Herba Ecliptae 20g, Fructus Ligustri Lucidi 20g, Hirudo 20g, Eupolyphaga Seu Steleophaga 20g, Colla Corii Asini 30g, Radix Bupleuri 15g, Radix Curcumae 20g and Radix Glycyrrhizae 15g by the following raw materials in weight medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100103973A CN1323711C (en) | 2005-09-27 | 2005-09-27 | Chinese medicine for treating liver cancer and carcinoma of pancreas |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100103973A CN1323711C (en) | 2005-09-27 | 2005-09-27 | Chinese medicine for treating liver cancer and carcinoma of pancreas |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1772255A CN1772255A (en) | 2006-05-17 |
| CN1323711C true CN1323711C (en) | 2007-07-04 |
Family
ID=36759507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100103973A Expired - Fee Related CN1323711C (en) | 2005-09-27 | 2005-09-27 | Chinese medicine for treating liver cancer and carcinoma of pancreas |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1323711C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102091302A (en) * | 2011-03-17 | 2011-06-15 | 南京中医药大学 | Compound traditional Chinese medicine with anti-hepatocarcinoma effect and application thereof |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102284040B (en) * | 2011-09-08 | 2013-11-20 | 鲍修惠 | Composition medicament for treating tumor |
| CN103007084B (en) * | 2012-12-28 | 2013-12-18 | 柳尧花 | Preparation method of traditional Chinese medicine for treating liver cancer |
| CN103977351A (en) * | 2014-05-23 | 2014-08-13 | 李绍礼 | Medicine composition for treating liver cancer |
| CN105663551A (en) * | 2016-01-28 | 2016-06-15 | 陈西成 | Traditional Chinese medicine preparation for patient suffering from pancreatic cancer to take after operation as well as preparation method |
| CN105521182A (en) * | 2016-01-28 | 2016-04-27 | 陈西成 | Preparation for treating pancreatic cancer and preparation method of preparation |
| CN107684564A (en) * | 2017-04-13 | 2018-02-13 | 昆明赛诺制药股份有限公司 | A kind of medicine for treating cancer of pancreas and preparation method thereof |
-
2005
- 2005-09-27 CN CNB2005100103973A patent/CN1323711C/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 肝病并发疼痛的中医治疗 刘文奇 等，中西医结合肝病杂志，第15卷第1期 2005 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102091302A (en) * | 2011-03-17 | 2011-06-15 | 南京中医药大学 | Compound traditional Chinese medicine with anti-hepatocarcinoma effect and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1772255A (en) | 2006-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101961479A (en) | Chinese medicinal composition for treating bellyache and preparation method thereof | |
| CN101766789B (en) | Chinese medicine composite for treating appendicitis and preparation method thereof | |
| CN102512630B (en) | Traditional Chinese medicine composition for treating gallbladder calculus | |
| CN101780253B (en) | Traditional Chinese medicine compound for treating intestinal abscess and preparation method thereof | |
| CN104758890A (en) | Traditional Chinese medicine composition for treating cough | |
| CN1323711C (en) | Chinese medicine for treating liver cancer and carcinoma of pancreas | |
| CN102631512B (en) | Traditional Chinese medicine composition for curing chronic colitis | |
| CN102302567B (en) | Stagnation-removing and stasis-removing Chinese patent medicine | |
| CN1507884A (en) | Traditional Chinese medicine powder and decoction composition for treating cancer | |
| CN104587186A (en) | Traditional Chinese medicinal composition for treating qi and blood deficiency | |
| CN102389547A (en) | Traditional Chinese medicine for treating diabetic foot | |
| CN101130034A (en) | Traditional Chinese medicine composition for treating gland hyperplasia | |
| CN103341122A (en) | Traditional Chinese medicine composition for treating gallstone | |
| CN103212013A (en) | Chinese medicinal composition for treating epigastric pain | |
| CN102973899B (en) | Traditional Chinese medicine composition for treating cholelithiasis | |
| CN102743437B (en) | Traditional Chinese medicine composition having function of clearing vivotoxin and preparing method thereof | |
| CN1413720A (en) | Chinese drugs for treating psoriasis and its preparation method | |
| CN1994415B (en) | Orally administered Chinese medicine for treating dysmenorrhea | |
| CN1263499C (en) | Chinese medicine for treating cancer | |
| CN108310111B (en) | Traditional Chinese medicine formula for benefiting qi and nourishing blood, preparation method and application thereof, medicated diet for benefiting qi and nourishing blood and preparation method thereof | |
| CN105079487A (en) | Traditional Chinese medicine composition for treating heat stranguria | |
| CN105434533A (en) | Traditional Chinese medicine composition for treating liver cancer | |
| CN105998737A (en) | Traditional Chinese medicinal composition for treating hypogastric pain | |
| CN104771622A (en) | Medicine for treating hepatic ascites | |
| CN104189433A (en) | Traditional Chinese medicine preparation for chronic appendicitis and preparation method of traditional Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070704 Termination date: 20110927 |